Expression of HMGB1 in Organs in a Rodent Model of Transient Ischemia

DOI Web Site Web Site 26 References
  • Kajiwara Ryo
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
  • Otaki Ryo
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
  • Inahara Yuya
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
  • Kamiya Koki
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
  • Negishi Hiroshi
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
  • Kobayashi Masato
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
  • Kumagawa Takahiro
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
  • Igarashi Takahiro
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
  • Shijo Katsunori
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
  • Moro Nobuhiro
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
  • Oshima Hideki
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
  • Maeda Takeshi
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
  • Asano Masatake
    Department of Pathology, Nihon University School of Dentistry, Tokyo, Japan
  • Yoshino Atsuo
    Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan

Bibliographic Information

Other Title
  • ラット一過性脳虚血モデルにおける全身臓器の HMGB1 の発現
  • ラット イッカセイ ノウキョケツ モデル ニ オケル ゼンシン ゾウキ ノ HMGB1 ノ ハツゲン

Search this article

Abstract

<p>Background: High mobility group box 1 (HMGB1) is a chromatin structural protein expressed ubiquitously inthe nuclei of mammalian cells. Increasing evidence suggests that inflammatory responses are involved in the progression of systemic injuries induced by a diverse range of insults, including stroke, trauma, tumors, and degenerative diseases. Whether HMGB1 expression in systemic organs is associated with transient ischemic attack (TIA)remains unclear. We hypothesized that HMGB1 expression after TIA would exacerbate systemic symptoms due toacute inflammation.Material and Methods: We performed transient bilateral and unilateral common carotid artery occlusion (2VOand 1VO) on Sprague‒Dawley (SD) male rats. Rats were randomized to the sham, 1VO, and 2VO groups. Thesham group underwent no procedure that involved common carotid artery occlusion. Common carotid arterieswere clamped for 30 minutes and, subsequently, reperfused for 24 hours. Brain, heart, liver, lung, spleen, kidneyand intestine tissue samples were collected for biochemical and histopathological analysis. Protein and mRNA expression were determined by western blot analysis and polymerase chain reaction (PCR).Results: HMGB1 expression increased in the brain, liver, spleen and intestine of the rat 1VO and 2VO models.In vivo results indicated high expression of HMGB1 in TIA, and the expression of MMP-9 and PKCδ in the cerebral cortex and hippocampus was regulated by HMGB1. In the 2VO model, the expression of CD11b and GFAPin the cerebral cortex was significantly increased compared with that in the control group (P < 0.001). HMGB1was translocated from the nucleus to the cytoplasm at early stages after TIA and then localized to the cytoplasm ofphagocytic microglia at later stages.Conclusion: HMGB1 expression increased in the systemic organs after TIA. HMGB1 promotes systemic inflammation, which mediates the immune response and tissue damage in the brain after TIA. Targeting HMGB1signaling may be a promising therapeutic approach for the treatment of TIA.</p>

Journal

References(26)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top